TERN-601

· Terns, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TERN-601, covering 2025-11-06 to 2026-08-10. Get the full timeline:

Most recent: Clinical Trial Results: A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity [Phase 2]

See pricing